Log In
Print
BCIQ
Print
Print this Print this
 

aldoxorubicin (formerly DOXO-EMCH, INNO-206)

  Manage Alerts
Collapse Summary General Information
Company CytRx Corp.
Description6-maleimidocaproyl hydrazone prodrug of doxorubicin
Molecular Target DNA
Mechanism of ActionTopoisomerase II inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today